Systemic inflammation an ‘important risk factor’ for stroke, ILD in rheumatoid arthritis

SAN DIEGO — Managing systemic inflammation is critical to reducing cardiovascular and pulmonary outcomes in patients with rheumatoid arthritis, according to a presenter at the 2024 Congress of Clinical Rheumatology West.
“Systemic inflammation is really an important risk factor for all kinds of comorbidities that we see,” Anja Strangfeld, MD, professor of epidemiology and health services research at the Charité – University Medicine Berlin and the German Rheumatism Research Center Berlin, told attendees.
Strangfeld presented findings on comorbidities and outcomes in RA

Read More

Postmenopausal hormone therapy use declines amidst risk-benefit concerns

A study reveals a sharp decline in menopausal hormone therapy use among U.S. women, highlighting disparities across racial and ethnic groups over two decades.

Read More

Postmenopausal hormone therapy use declines amidst risk-benefit concerns

A study reveals a sharp decline in menopausal hormone therapy use among U.S. women, highlighting disparities across racial and ethnic groups over two decades.

Read More

Plant polyphenols: The secret to living longer and healthy aging?

Plant polyphenols show promise in combating aging, supporting mitochondrial health and reducing inflammation, potentially improving quality of life for seniors.

Read More

Plant polyphenols: The secret to living longer and healthy aging?

Plant polyphenols show promise in combating aging, supporting mitochondrial health and reducing inflammation, potentially improving quality of life for seniors.

Read More